Lpl Financial LLC Zynerba Pharmaceuticals, Inc. Transaction History

Lpl Financial LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.87 - $1.36 $384 - $601	-442 Reduced 3.4%	12,563 $9,000
Q2 2022 Aug 12, 2022	BUY	$0.86 - $2.06 $344 - $824	400 Added 3.17%	13,005 $15,000
Q1 2022 May 16, 2022	BUY	$1.83 - $3.02 $466 - $770	255 Added 2.06%	12,605 $26,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $25,081 - $37,448	-8,709 Reduced 41.36%	12,350 $36,000
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $5,650 - $8,126	-1,519 Reduced 6.73%	21,059 $89,000
Q2 2021 Aug 13, 2021	SELL	$3.83 - $5.98 $3,443 - $5,376	-899 Reduced 3.83%	22,578 $119,000
Q1 2021 May 14, 2021	BUY	$3.33 - $8.76 $34,535 - $90,849	10,371 Added 79.13%	23,477 $109,000
Q4 2020 Feb 12, 2021	BUY	$3.27 - $4.64 $5,650 - $8,017	1,728 Added 15.19%	13,106 $43,000
Q3 2020 Nov 09, 2020	BUY	$3.23 - $4.3 $1,663 - $2,214	515 Added 4.74%	11,378 $38,000
Q2 2020 Aug 13, 2020	BUY	$3.31 - $6.54 $797 - $1,576	241 Added 2.27%	10,863 $37,000
Q1 2020 May 14, 2020	BUY	$2.9 - $6.16 $30,803 - $65,431	10,622 New	10,622 $41,000
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $260,752 - $398,333	-46,480 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$7.56 - $15.44 $63,957 - $130,622	8,460 Added 22.25%	46,480 $351,000
Q2 2019 Aug 09, 2019	BUY	$5.4 - $15.5 $205,308 - $589,310	38,020 New	38,020 $515,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.